Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Schenkein David P, Director. Officer active across 5 companies, notably AGIOS PHARMACEUTICALS, INC.. In total, 32 disclosures have been logged. Breakdown: 0 buy · 2 sells. Total volume traded: €2.1m. History available since 28 May 2021. The latest transaction was filed on 3 June 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Schenkein David P
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Schenkein David P is Administrateur. He has 32 filings in total, and across the sampled recent filings from 2016-01-05 to 2026-06-05, the reported sell volume is EUR 2083291 and the most common transaction nature is Levée d'options. His recent filings concern AGIOS PHARMACEUTICALS, INC., Denali Therapeutics Inc. and Regeneron Pharmaceuticals, INC., as well as AGIOS PHARMACEUTICALS INC.